Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

SGXC:9G2 Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	2.48	2.84	3.16	11.05	15.84	10.29
Short-Term Investments	-	0.54	0.04	0.25	0.27	0.21
Cash & Short-Term Investments	2.48	3.38	3.21	11.3	16.11	10.51
Cash Growth	-	5.45%	-71.62%	-29.86%	53.32%	-
Accounts Receivable	2.04	1.43	0.94	1.46	1.6	0.93
Other Receivables	-	0.17	0.17	0.29	2.41	0.95
Receivables	2.04	1.59	1.12	1.74	4.01	1.87
Inventory	0.13	0.11	0.1	0.11	0.1	0.11
Prepaid Expenses	-	0.22	0.23	0.26	0.12	0.15
Other Current Assets	0.28	0	0.01	0.03	0.26	1.04
Total Current Assets	4.93	5.31	4.66	13.44	20.59	13.68
Property, Plant & Equipment	113.11	116.19	130.41	142.1	138.24	141.22
Other Intangible Assets	0	0.01	0.02	0.03	0.04	0.02
Long-Term Accounts Receivable	-	-	-	-	0.06	0.07
Other Long-Term Assets	4.25	3.2	3.67	3.95	15.43	17.09
Total Assets	122.3	124.71	138.76	159.52	174.36	172.08

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	14.23	0.61	0.58	0.76	0.46	0.54
Accrued Expenses	-	3.28	3.88	5.08	17	14.5
Short-Term Debt	-	5.13	-	1.9	4.04	-
Current Portion of Long-Term Debt	15.5	4.34	3.82	22.81	15.27	13.43
Current Portion of Leases	3.18	1.78	2.63	2.49	2.28	2.1
Current Unearned Revenue	-	0.24	0.15	0.25	0.02	0.02
Other Current Liabilities	0.27	1.97	1.48	19.64	11.06	1.28
Total Current Liabilities	33.17	17.35	12.54	52.94	50.13	31.87
Long-Term Debt	10.78	18.79	9.69	21.12	29.92	38.67
Long-Term Leases	29.17	28.18	29.96	32.45	35.79	38.06
Other Long-Term Liabilities	4.91	4.76	4.82	8.09	4.46	4.3
Total Liabilities	78.02	69.07	57.01	114.6	120.31	112.9

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	197.4	191.46	190.86	104.84	102.55	82.89
Retained Earnings	-148.04	-130.75	-103.69	-66.25	-48.18	-35.75
Comprehensive Income & Other	-5.08	-5.08	-5.43	6.33	-0.32	12.04
Shareholders' Equity	44.28	55.64	81.74	44.93	54.05	59.18
Total Liabilities & Equity	122.3	124.71	138.76	159.52	174.36	172.08

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	58.62	58.21	46.1	80.77	87.3	92.26
Net Cash (Debt)	-56.14	-54.83	-42.89	-69.48	-71.19	-81.75
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.05	-0.05	-0.05	-0.10	-0.11	-0.15
Filing Date Shares Outstanding	1,231	1,062	1,048	893.83	645.16	533
Total Common Shares Outstanding	1,231	1,062	1,048	337.99	645.16	533
Working Capital	-28.24	-12.03	-7.89	-39.5	-29.53	-18.19
Book Value Per Share	0.04	0.05	0.08	0.13	0.08	0.11
Tangible Book Value	44.28	55.63	81.73	44.9	54.02	59.16
Tangible Book Value Per Share	0.04	0.05	0.08	0.13	0.08	0.11
Buildings	-	-	-	-	-	3.3
Machinery	-	77.25	77.9	77.66	72	69.56
Construction In Progress	-	-	-	-	42.94	42.69

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error